Calm before the StormIt's been a really good run after Biogen's approval of Aducanumab. The SP and Market Cap have stabilized and there is a contant demand for Shares. Today over 100K and its not even Noon. I believe there will be some sort of Deal put in place by this Year and for now it seems everyone is Buying and Holding. Also at a very attractive price!